Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Monocacy Therapeutics Inc.6.1remove | Claris Biotherapeutics, Inc.6.3remove | Aclarity Genomics, Inc.6.1remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 6.1 | 6.3 | 6.1 |
| IPO signal score | 12.2 | 12.6 | 12.2 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE+4.0 | STABLE+0.7 | STABLE+5.0 |
| Company | |||
| Stage | private | private | private |
| Sector | Technology | Technology | Technology |
| Headquarters | MONROVIA, United States | HALF MOON BAY, United States | MORRISVILLE, United States |
| Founded | 2025 | not on record | 2024 |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $275K | $56M | $5M |
| Latest round | Private Placement $125K | Private Placement $56M | Private Placement $5M |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 4 | 3 | 1 |
| Confidence | 63% | 58% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.